ANTITHYROID ANTIBODIES IN ITALIAN SCLERODERMA PATIENTS - ASSOCIATION OF ANTITHYROID PEROXIDASE (ANTI-TPO) ANTIBODIES WITH HLA-DR15

Citation
M. Molteni et al., ANTITHYROID ANTIBODIES IN ITALIAN SCLERODERMA PATIENTS - ASSOCIATION OF ANTITHYROID PEROXIDASE (ANTI-TPO) ANTIBODIES WITH HLA-DR15, Clinical and experimental rheumatology, 15(5), 1997, pp. 529-534
Citations number
33
Categorie Soggetti
Rheumatology
ISSN journal
0392856X
Volume
15
Issue
5
Year of publication
1997
Pages
529 - 534
Database
ISI
SICI code
0392-856X(1997)15:5<529:AAIISP>2.0.ZU;2-P
Abstract
Objective: To evaluate the frequency of anti-thyroid antibodies in a g roup of patients with scleroderma (SSc) and to analyze their genetic a ssociation with the HLA class II antigens. Methods: Anti-thyroglobulin (anti-TG) and anti-thyroid peroxidase (anti-TPO) antibodies were meas ured by hemagglutination techniques. Thyroid function was evaluated by determining the levels of FT3, FT4 and TSH. HLA-DR typing was carried out using a standard complement-dependent microlymphocytotoxicity tes t. Results: The proportions of patients with anti-TG and anti-TPO anti bodies were 12% (10/85) and 19% (16/85) respectively. Two patients wit h anti-thyroid antibodies had overt hypothyroidism and shared the HLA- DR3 allele. The SSc subjects with anti-TPO antibodies showed a higher frequency of the HLA-DR15 allele than the patients without these antib odies. Conclusion: A considerable number of patients with scleroderma have antibodies to thyroid antigens without exhibiting any alterations of their thyroid function. HLA-DR15 is all immunogenic marker for the formation of antibodies against microsomal thyroid peroxidase.